<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-03T01:20:29+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>低溶解性药物平衡溶解度测定的影响因素研究</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/be7yQap5XsobI2dGb1lsGQ</id>
    <link href="https://mp.weixin.qq.com/s/be7yQap5XsobI2dGb1lsGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>自今日起，药品审评只发补一次</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/X7Praur5ye4TEjVz426iCQ</id>
    <link href="https://mp.weixin.qq.com/s/X7Praur5ye4TEjVz426iCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【干货】基于原料药性质的口服固体制剂生产工艺路线选择</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/U9ttCWo25MIic7T0SVq66A</id>
    <link href="https://mp.weixin.qq.com/s/U9ttCWo25MIic7T0SVq66A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【干货】最新ICH-Q1、Q9、Q10、Q3D、Q6A、E4、M4指导原则培训视频免费看</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/e0ZLDvBcfkd_0vThJzcbkw</id>
    <link href="https://mp.weixin.qq.com/s/e0ZLDvBcfkd_0vThJzcbkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国仿制药质量关键影响因素分析</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/MfgALe-WDk_TF2X2gYirtA</id>
    <link href="https://mp.weixin.qq.com/s/MfgALe-WDk_TF2X2gYirtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T细胞疗法最新研究进展</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/kcO0CHnYCgWWZQtXW3mm9A</id>
    <link href="https://mp.weixin.qq.com/s/kcO0CHnYCgWWZQtXW3mm9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布晚期肝细胞癌临床试验终点技术指导原则！</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/rgwPhd-pFVEEl4GKwZNWwg</id>
    <link href="https://mp.weixin.qq.com/s/rgwPhd-pFVEEl4GKwZNWwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官方解读：真实世界数据不能取代现有临床评价路径</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/lTgA0AuABMqT17SvlrprQA</id>
    <link href="https://mp.weixin.qq.com/s/lTgA0AuABMqT17SvlrprQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【收藏】IND、NDA的溶出方法开发确认</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/W6WXate1kFQX8qFCax3HrA</id>
    <link href="https://mp.weixin.qq.com/s/W6WXate1kFQX8qFCax3HrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【课件分享】原料药变更管理与发补回复策略浅析</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/3lie8N0ogAXifORkTCyOXA</id>
    <link href="https://mp.weixin.qq.com/s/3lie8N0ogAXifORkTCyOXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（47）-血小板减少症</title>
    <updated>2020-11-29T19:26:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/UcIRb2Lnb7n06zlzS5Rerg</id>
    <link href="https://mp.weixin.qq.com/s/UcIRb2Lnb7n06zlzS5Rerg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE刚刚更新发布《常见一般性技术问题解答》</title>
    <updated>2020-11-29T19:26:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/YxtH8WkaJQE28Do3VG85AQ</id>
    <link href="https://mp.weixin.qq.com/s/YxtH8WkaJQE28Do3VG85AQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CHO细胞表达重组单克隆抗体载体的构建策略</title>
    <updated>2020-11-29T19:26:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/mtdPNE24wTRfsVktSbNJxg</id>
    <link href="https://mp.weixin.qq.com/s/mtdPNE24wTRfsVktSbNJxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新ICH指导原则 PPT课件</title>
    <updated>2020-11-28T20:30:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/mKb3-EjO0h0sdFfsJeAttQ</id>
    <link href="https://mp.weixin.qq.com/s/mKb3-EjO0h0sdFfsJeAttQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传办申报最新问与答</title>
    <updated>2020-11-28T20:30:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/OUVDODufReectfXK0KRkvg</id>
    <link href="https://mp.weixin.qq.com/s/OUVDODufReectfXK0KRkvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周药闻丨诺华CD20单抗上市申请拟纳入优先审评 礼来BTK抑制剂获批临床</title>
    <updated>2020-11-28T20:30:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/_w1cYC2ZCH_LUX6DpzEeCQ</id>
    <link href="https://mp.weixin.qq.com/s/_w1cYC2ZCH_LUX6DpzEeCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>围城——工作篇</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/058t-cHI3-w29dUU7IP2UQ</id>
    <link href="https://mp.weixin.qq.com/s/058t-cHI3-w29dUU7IP2UQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布发布《中药复方制剂生产工艺研究技术指导原则（试行）》</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/PF0TK8PGPoq3fywZJpobJA</id>
    <link href="https://mp.weixin.qq.com/s/PF0TK8PGPoq3fywZJpobJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注册申报CPP文件，CDE最新规定来了！</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/3FbFYBBWduolPsYR3PDegg</id>
    <link href="https://mp.weixin.qq.com/s/3FbFYBBWduolPsYR3PDegg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国在研肿瘤药创新性分析</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/CgcznI53wxsx-U4YTgvLtA</id>
    <link href="https://mp.weixin.qq.com/s/CgcznI53wxsx-U4YTgvLtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>